Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma

Gang Peng , Yang Ke , Tao Wang , Yiming Feng , Yuehua Li , Gang Wu

Current Medical Science ›› 2011, Vol. 31 ›› Issue (6) : 857 -860.

PDF
Current Medical Science ›› 2011, Vol. 31 ›› Issue (6) : 857 -860. DOI: 10.1007/s11596-011-0691-x
Article

Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma

Author information +
History +
PDF

Abstract

Surgical excision and postoperative radiotherapy are widely accepted therapeutic modalities for sinonasal teratocarcinosarcoma (SNTCS). Previous studies have shown that intensity-modulated radiation therapy (IMRT) is safe and effective for the treatment of some sinonasal malignancies. We hypothesize that use of IMRT for SNTCS may result in clinical benefits. We report here two cases of SNTCS that were treated by IMRT. One patient was given extensive IMRT involving elective neck irradiation. Follow-up examinations revealed no recurrence and metastasis 3.5 years after IMRT. Another patient simultaneously suffered from multiple systematical diseases and was administered involved-field radiotherapy. He was found to have a marginal recurrence during the follow up and eventually died 8 months after disease diagnosis. It was suggested in this study that appropriate use of IMRT for the treatment of SNTCS may achieve excellent local control.

Keywords

sinonasal teratocarcinosarcoma / radiotherapy / head and neck cancer / intensity-modulated radiation therapy / paranasal sinus

Cite this article

Download citation ▾
Gang Peng, Yang Ke, Tao Wang, Yiming Feng, Yuehua Li, Gang Wu. Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma. Current Medical Science, 2011, 31(6): 857-860 DOI:10.1007/s11596-011-0691-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

WeiS., CarrollW., LazenbyA., et al.. Sinonasal teratocarcinosarcoma: report of a case with review of literature and treatment outcome. Ann diagn pathol, 2008, 12(6): 415-425

[2]

BudrukkarA., AgarwalJ.P., KaneS., et al.. Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J laryngol otol, 2010, 124(7): 739-743

[3]

SmithS.L., HesselA.C., LunaM.A., et al.. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch otolaryngol head & neck surg, 2008, 134(6): 592-595

[4]

HeffnerD.K., HyamsV.J.. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses A clinicopathologic study of 20 cases. Cancer, 1984, 53(10): 2140-2154

[5]

SharmaH.S., AbdullahJ.M., OthmanN.H., et al.. Teratocarcinosarcoma of the nasal cavity and ethmoid. J laryngolotol, 1998, 112(7): 682-686

[6]

TakasakiK., SakihamaN., TakahashiH.. A case with sinonasal teratocarcinosarcoma in the nasal cavity and ethmoid sinus. Eur Arch Otorhinolaryngol, 2006, 263(6): 586-591

[7]

ParsonsJ.T., MendenhallW.M., MancusoA.A., et al.. Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses. Int J Radiat Oncol Biol Phys, 1988, 14(1): 11-22

[8]

DalyM.E., ChenA.M., BucciM.K., et al.. Intensitymodulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys, 2007, 67(1): 151-157

[9]

LaiS.Z., LiW.F., ChenL., et al.. How does intensitymodulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys, 2011, 80(3): 661-668

[10]

SaarilahtiK., KouriM., CollanJ., et al.. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol, 2005, 74(3): 251-258

[11]

MadaniI., BonteK., VakaetL., et al.. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys, 2009, 73(2): 424-432

[12]

ShanmugaratnamK., KunaratnamN., ChiaK.B., et al.. Teratoid carcinosarcoma of the paranasal sinuses. Pathology, 1983, 15(4): 413-419

[13]

CarrizoF., Pineda-DaboinK., NetoA.G., et al.. Pharyngeal teratocarcinosarcoma: review of the literature and report of two cases. Ann diagn pathol, 2006, 10(6): 339-342

[14]

RotenbergB., El-HakimH., LodhaA., et al.. Nasopharyngeal teratocarcinosarcoma. Int J Pediatr Otorhinolaryngol, 2002, 62(2): 159-164

[15]

EndoH., HiroseT., KuwamuraK.I., et al.. Case report: Sinonasal teratocarcinosarcoma. Pathol Intern, 2001, 51(2): 107-112

[16]

OgawaT., IkedaK., WatanabeM., et al.. A case report of sinonasal teratocarcinosarcoma. Tohoku J Exp Med, 2000, 190(1): 51-59

[17]

ChaoK.K., EngT.Y., BarnesJ., et al.. Sinonasal teratocarcinosarcoma. Am J Clin Oncol, 2004, 27(1): 29-32

[18]

PaiS.A., NareshK.N., MasihK., et al.. Teratocarcinosarcoma of the paranasal sinuses: a clinicopathologic and immunohistochemical study. Human pathology, 1998, 29(7): 718-722

[19]

BatsakisJ.G., el-NaggarA.K., LunaM.A.. Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol, 1995, 104(6): 496-500

[20]

DuthoyW., BoterbergT., ClausF., et al.. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer, 2005, 104(1): 71-82

[21]

ClausF., MijnheerB., RaschC., et al.. Report of a study on IMRT planning strategies for ethmoid sinus cancer. Strahlenther Onkol, 2002, 178(10): 572-576

AI Summary AI Mindmap
PDF

99

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/